Rockline Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.06M | Buy |
32,637
+214
| +0.7% | +$39.7K | 1.43% | 15 |
|
|
2025
Q1 | $6.79M | Buy |
32,423
+386
| +1% | +$80.9K | 1.89% | 14 |
|
|
2024
Q4 | $5.69M | Buy |
32,037
+1,428
| +5% | +$254K | 1.52% | 15 |
|
|
2024
Q3 | $6.04M | Buy |
30,609
+715
| +2% | +$141K | 1.71% | 13 |
|
|
2024
Q2 | $5.13M | Buy |
29,894
+1,113
| +4% | +$191K | 1.58% | 13 |
|
|
2024
Q1 | $5.24M | Buy |
28,781
+477
| +2% | +$86.9K | 1.83% | 12 |
|
|
2023
Q4 | $4.39M | Buy |
+28,304
| New | +$4.39M | 1.82% | 14 |
|